Veracyte, Inc. (VCYT) is a publicly traded Healthcare sector company. As of May 21, 2026, VCYT trades at $45.20 with a market cap of $3.31B and a P/E ratio of 40.34. VCYT moved +8.37% today. Year to date, VCYT is +3.58%; over the trailing twelve months it is +56.86%. Its 52-week range spans $22.61 to $50.71. Analyst consensus is buy with an average price target of $45.28. Rallies surfaces VCYT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
VCYT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VCYT recently traded at $45.20. Market cap is $3.31B. P/E ratio is 40.34. Revenue is $541.74M.
| Metric | Value |
|---|---|
| Price | $45.20 |
| Market Cap | $3.31B |
| P/E Ratio | 40.34 |
| EPS | $1.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.71 |
| 52-Week Low | $22.61 |
| Volume | 500 |
| Avg Volume | 0 |
| Revenue (TTM) | $541.74M |
| Net Income | $88.01M |
| Gross Margin | 70.92% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $517.14M | $66.35M | $0.84 |
| 2023 | $361.05M | $-74.40M | $-1.02 |
| 2022 | $296.54M | $-36.56M | $-0.51 |
| 2021 | $219.51M | $-75.56M | $-1.11 |
8 analysts cover VCYT: 0 strong buy, 6 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $45.28.